Description Retatrutide is an investigational multi-receptor peptide agonist that combines activity at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is a next-generation metabolic therapy designed to leverage the synergistic effects of these three hormonal pathways to improve energy expenditure, insulin sensitivity, and appetite control. Mechanistically, GLP-1 and GIP agonism enhances glucose-dependent insulin secretion, delays…
Description Selank is a synthetic heptapeptide with anxiolytic and nootropic properties, derived from tuftsin. It is commonly studied for its effects on stress modulation, cognitive enhancement, and neuroimmune regulation.